SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL

TOXOPLASMOSIS AND RISK OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND MAJOR DEPRESSIVE DISORDER: A REVIEW ARTICLE

SERO-PREVALENCE OF ANTI- TOXOPLASMA GONDII ANTIBODIES AMONG PATIENTS WITH NEUROPSYCHIATRIC DISORDERS: EPILEPSY AND DEPRESSION

A RVIEW ON TOXOPLASMOSIS IN HIV-INFECTED PATIENTS

TOXOPLASMOSIS IN VACCINATED COVID-19 PATIENTS

Investigation of the relationship between schizophrenia and toxoplasmosis in Van province, Turkey

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS ASSOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA

TOXOPLASMOSIS AND NEUROLOGICAL DISEASES IN CHILDREN: A SERIOUS RISK OR MERE ASSOCIATION

Insights into the interplay of latent toxoplasmosis, testosterone, cortisol and oxidative stress in screened schizophrenic patients in Egypt

The Association Between Toxoplasmosis and Some Psychiatric Disorders: A case control study